Society of Urologic Oncology Annual Meeting (SUO) | Conference

Adam J. Gadzinski, MD, MS, on Up-and-Coming Research for Urologic Oncology
January 07, 2021

The expert in urologic oncology spoke about new innovations that he believes will aid in treating patients with urologic cancers.

Ramaprasad Srinivasan, MD, PhD, on Next Steps for MK-6482 in VHL-Associated Disease
December 29, 2020

Study results indicated that the small molecule HIF-2α inhibitor MK-6482 induced positive results in patients with certain Von Hippel-Lindau disease–associated solid tumors.

Adam J. Gadzinski, MD, MS, on Study Results Assessing the Impact of Telemedicine on Patient-Reported Outcomes
December 21, 2020

The study was designed to determine the impact of a rurally focused telemedicine program on patient outcomes.